Key Takeaways
- Forus raised a new round from Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup, Pear VC, Index Ventures, Team8, Picture Capital, Gil Capital, Radical Ventures, Y Combinator, M12, PSP Growth, Neuberger’s Outpost Ventures, McKesson Ventures, FCA Venture Partners, Sanofi Ventures, AIX Ventures, Insight Partners, Brewer Lane Ventures, Crystal Venture Partners, SV Angel, Avid Ventures, Verissimo Ventures, Blank Ventures, Arch, Sound Ventures, Alumni Ventures, Link Ventures, Redesign Health, RRE Ventures, Builders Vision, Barclays Climate Ventures, the Prince Albert II of Monaco Foundation, Monaco Asset Management (ReOcean Fund), BDT & MSD Partners (Oceans Catalyst), DCP, Archetype, Circle Ventures, Era, Chailease, K8 Fund, CAVU Consumer Partners, B4 Capital, Type Capital, Matchstick Ventures, Headwater Ventures.
- Sector: Healthcare, Healthtech & Medtech, Artificial Intelligence (AI), Financial Services & Fintech, Technology, Software & Gaming, Business Services, Consumer.
- Geography: United States.
Analysis
New York City's innovation engine is firing on all cylinders, with a significant influx of capital directed towards artificial intelligence and health technology ventures. This past week saw several key players in these sectors secure substantial funding rounds, underscoring the continued investor appetite for solutions addressing complex healthcare access, cybersecurity threats, and operational efficiencies.
Leading the charge is Forus, an AI-driven platform designed to streamline patient access to prescribed therapies by connecting doctors, pharmacies, payers, and biopharmaceutical companies. The company announced a significant $123 million Series B round, backed by a formidable group of investors including Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup, and Pear VC. This latest infusion brings Forus's total reported equity funding to $160 million since its 2023 inception, positioning it as a major force in health tech logistics.
The cybersecurity space also saw robust investment, with Frame Security raising $50 million in venture funding. This platform focuses on educating employees to identify and counter sophisticated AI-driven social engineering tactics, deepfakes, and phishing attempts. The round was spearheaded by Index Ventures, Team8, and Picture Capital, with contributions from Assaf Rappaport and Gil Capital. Founded in 2025, Frame Security is addressing a critical vulnerability in the modern corporate environment.
Further demonstrating the AI trend, Cinder, a trust and safety platform utilizing AI agents to combat digital abuse and fraud, secured $41 million in Series B financing. This round was led by Radical Ventures and included participation from Accel, Y Combinator, M12, PSP Growth, and Neuberger’s Outpost Ventures. Cinder's total funding now stands at $55 million, reflecting strong market validation for its approach to online safety.
The legal tech sector is also embracing AI, with Sandstone, an AI-native workflow automation platform for in-house legal teams, filing for $39.6 million in funding. This filing indicated a total offering of $41.3 million with thirty investors. Additionally, BranchLab, an AI platform aiding pharmaceutical companies in therapy commercialization, garnered $26 million in Series A funding from McKesson Ventures, FCA Venture Partners, Sanofi Ventures, and AIX Ventures. GovWell, an AI operating system for local government agencies, also closed a $25 million Series A round led by Insight Partners.
Other notable financings include Novella, an AI-powered wholesale insurance brokerage, which raised $21 million from a syndicate including Brewer Lane Ventures, BoxGroup, Crystal Venture Partners, SV Angel, Avid Ventures, Verissimo Ventures, Blank Ventures, and Arch. Anomaly Insights, an AI payer intelligence platform for healthcare providers, secured $17 million led by Sound Ventures, with support from Alumni Ventures, Link Ventures, Redesign Health, and RRE Ventures. In the clean tech arena, ECOncrete, a bio-enhancing marine construction firm, received $14 million from investors such as Builders Vision, Barclays Climate Ventures, and the Prince Albert II of Monaco Foundation.
The consistent flow of capital into AI-centric businesses, particularly within healthcare and enterprise solutions, highlights a strategic shift in investment priorities. These companies are not only addressing critical market needs but are also leveraging advanced technology to create scalable and impactful solutions, signaling a promising trajectory for the NYC tech ecosystem.